{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:30:23Z","timestamp":1761514223695},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.radonc.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T09:12:32Z","timestamp":1529399552000},"page":"492-497","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac mortality in limited-stage small cell lung cancer"],"prefix":"10.1016","volume":"128","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad H.","family":"Fakhreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqar","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Brian","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin S.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.06.011_b0005","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.06.011_b0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.06.011_b0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/JTO.0b013e31828e8996","article-title":"Impact of PET staging in limited-stage small-cell lung cancer","volume":"8","author":"Xanthopoulos","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0030","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ijrobp.2010.07.284","article-title":"RTOG 0229: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full dose radiotherapy (XRT) followed by resection and consolidative therapy for LA-NSCLC","volume":"78","author":"Suntharalingam","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0045","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90\u202fGy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trial for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2017.09.004","article-title":"Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy","volume":"125","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.06.011_b0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.1997.15.3.893","article-title":"Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study","volume":"15","author":"Jeremic","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2003.10.021","article-title":"70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808","volume":"59","author":"Bogart","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1993.11.2.336","article-title":"Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group","volume":"11","author":"Murray","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0080","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/annonc\/mdq042","article-title":"Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer","volume":"21","author":"Hardy","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/cncr.22845","article-title":"The risk of death from heart disease in patients with non\u2013small-cell lung cancer who receive postoperative radiotherapy: analysis of the surveillance, epidemiology, and end results database","volume":"110","author":"Lally","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.06.011_b0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijrobp.2017.10.031","article-title":"Trends in cardiac mortality in patients with locally advanced non-small cell lung cancer","volume":"100","author":"Haque","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1634\/theoncologist.2015-0348","article-title":"Stereotactic radiotherapy for stage I small cell lung cancer","volume":"21","author":"Verma","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2018.06.011_b0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2016.10.041","article-title":"Multi-institutional experience of stereotactic ablative radiation therapy for stage I small cell lung cancer","volume":"97","author":"Verma","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lungcan.2016.11.009","article-title":"Trends in stereotactic body radiation therapy for stage I small cell lung cancer","volume":"103","author":"Stahl","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2018.06.011_b0110","unstructured":"Clinicaltrials.gov. Radiation Therapy Regimens in Treating Patients with Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00632853 Accessed October 31, 2017."},{"key":"10.1016\/j.radonc.2018.06.011_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non\u2013small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0120","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ijrobp.2010.12.072","article-title":"Positron emission tomography\u2013guided intensity modulated radiotherapy for limited-stage small-cell lung cancer","volume":"82","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijrobp.2013.05.040","article-title":"Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer","volume":"87","author":"Shirvani","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2014.09.042","article-title":"Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer","volume":"91","author":"Xia","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.011_b0135","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3892\/etm.2015.2835","article-title":"Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer","volume":"10","author":"Liu","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.radonc.2018.06.011_b0140","doi-asserted-by":"crossref","first-page":"e172032","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer: final results of a phase 2 study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/0284186X.2013.769063","article-title":"Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer","volume":"52","author":"Colaco","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0150","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1002\/cncr.30870","article-title":"Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer","volume":"123","author":"Rwigema","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.06.011_b0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","article-title":"A cardiac contouring atlas for radiotherapy","volume":"122","author":"Duane","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.011_b0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.06.011_b0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4330\/wjc.v8.i6.368","article-title":"Incidence and trends of cardiovascular mortality after common cancers in young adults: analysis of surveillance, epidemiology, and end-results program","volume":"8","author":"Al-Kindi","year":"2016","journal-title":"World J Cardiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018303116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018303116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T15:18:24Z","timestamp":1536160704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018303116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0167814018303116"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.06.011","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac mortality in limited-stage small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}